These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27765694)

  • 21. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
    Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Chang X; Zhang F; Liu T; Wang W; Guo H
    Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological characteristics and radiographic correlates of complex renal cysts.
    Reese AC; Johnson PT; Gorin MA; Pierorazio PM; Allaf ME; Fishman EK; Netto GJ; Pavlovich CP
    Urol Oncol; 2014 Oct; 32(7):1010-6. PubMed ID: 25022857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma.
    Goldman SM
    J Urol; 1998 Oct; 160(4):1586-7. PubMed ID: 9751416
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.
    Obata J; Tanaka N; Mizuno R; Kanao K; Mikami S; Matsumoto K; Kosaka T; Kikuchi E; Jinzaki M; Oya M
    BJU Int; 2016 Oct; 118(4):598-603. PubMed ID: 26780664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm.
    Andrade HS; Zargar H; Akca O; Caputo PA; Ramirez D; Kara O; Stein RJ; Chueh SC; Kaouk JH
    J Endourol; 2016 Apr; 30(4):379-83. PubMed ID: 26486995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study.
    Lee H; Jeong CW; Kwak C; Kim HH; Seo SI; Lee HM; Oh JJ; Lee SC; Hong SK; Lee SE; Byun SS
    Clin Genitourin Cancer; 2017 Dec; 15(6):e935-e941. PubMed ID: 28558989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of tubulocystic carcinoma of the kidney with aggressive features.
    Maeda Y; Goto K; Honda Y; Kuroda N; Sentani K; Yasui W; Hayashi T; Teishima J; Matsubara A; Nakamura Y; Toyota N; Iida M; Awai K
    Jpn J Radiol; 2016 Apr; 34(4):307-11. PubMed ID: 26830902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.
    Tsui KH; Shvarts O; Barbaric Z; Figlin R; de Kernion JB; Belldegrun A
    J Urol; 2000 Feb; 163(2):437-41. PubMed ID: 10647649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postoperative evaluation of renal cell carcinoma in the abdominal computed tomography].
    Kurihara N; Tazawa S; Suzuki Y; Kato M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun; 53(6):641-8. PubMed ID: 8337106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinics in diagnostic imaging (135). Cystic renal cell carcinoma.
    Pojchamarnwiputh S; Muttarak M; Sriplakich S
    Singapore Med J; 2011 May; 52(5):384-7; quiz 388. PubMed ID: 21633780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A progressively enlarging cystic renal mass in a previously healthy 48-year-old woman.
    Chapman VM; Hazelton TR
    Cancer Control; 2000; 7(1):63, 70-1. PubMed ID: 10740662
    [No Abstract]   [Full Text] [Related]  

  • 37. Bosniak Classification and other Variables in the Prediction of Renal Cystic Masses.
    Keseroglu B; Ozgur BC; Tastemur S; Irkilata L; Doluoglu OG; Yuceturk CN
    J Coll Physicians Surg Pak; 2019 May; 29(5):456-458. PubMed ID: 31036118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350-1355.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):450-451. PubMed ID: 28416104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tumor volume on survival in patients with renal cell carcinoma.
    Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
    Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.